PositiveID Corp (OTCMKTS:PSID) disclosed that it concluded the Phase II assessment of its Firefly Dx Polymerase Chain Reaction pathogen detection system. During the testing process, the company noticed multiple organisms with a multiplex test designed to simultaneously check for up to four pathogens.
What is the use?
The new Firefly Dx system is designed by PositiveID to provide diagnostic results by using a handheld device. The results are provided in real-time. It indicates that the places where there no existing systems or advanced labs, there also the tests can be conducted without any problem. There is no need of any lab-based equipment. The best use of the pathogen detection system is that it provides results in few hours. There is no need to wait for days to get the results. In multiplex testing, PositiveID delivered encouraging PCR results.
The system
Results on pathogen detection system can be immediately received and processed in-situ through SMART phone interface or personal computer loaded with a specialized, HTML application. It should also have Cloud-based data sharing and storage features. The portability, low cost, ease-of-use, and assay flexibility are the main features of system. The objective is to instill confidence in the user to get accurate diagnostic results in remote environments.
The momentum
In unrelated news, it is important to highlight that PositiveID is one of the target firms of promotional emails. In last trading session, the stock price of PSID declined 4.60% to close at $0.0228.The decline came at a share volume of 5.51 million compared to the average volume of 4.36 million. Last week, the stock price managed to hold its gains.
The pumps
PositiveID Corp (OTCMKTS:PSID) pumpers have done put in considerable efforts for relatively little money while promoting the firm in the past few months. The latest series of pumps by notorious names like Research Driven Alerts, DavidCohen and MichaelStone was disclosed as getting a compensation amount of just $7,000.
